120 related articles for article (PubMed ID: 38247317)
1. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
Xu J; Bock CH; Janisse J; Woo J; Cher ML; Ginsburg K; Yacoub R; Goodman M
Cancer; 2024 May; 130(10):1797-1806. PubMed ID: 38247317
[TBL] [Abstract][Full Text] [Related]
2. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
3. Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G; De Luca S; Oderda M; Munoz F; Krengli M; Allis S; Baima CG; Barale M; Bartoncini S; Beldì D; Bellei L; Bellissimo AR; Bernardi D; Biamino G; Billia M; Borsa R; Cante D; Castelli E; Cattaneo G; Centrella D; Collura D; Coppola P; Dalmasso E; Di Stasio A; Fasolis G; Fiorio M; Garibaldi E; Girelli G; Griffa D; Guercio S; Migliari R; Molinaro L; Montefiore F; Montefusco G; Moroni M; Muto G; Ponti di Sant'Angelo F; Ruggiero L; Ruo Redda MG; Serao A; Squeo MS; Stancati S; Surleti D; Varvello F; Volpe A; Zaramella S; Zarrelli G; Zitella A; Bollito E; Gontero P; Porpiglia F; Galassi C; Bertetto O;
JAMA Netw Open; 2023 Oct; 6(10):e2338039. PubMed ID: 37847502
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, Predictors, and Implications for Appropriate Use of Active Surveillance Management Among Black Men Diagnosed With Low-risk Prostate Cancer.
Taku N; Narayan V; Wang X; Vapiwala N
Am J Clin Oncol; 2019 Jun; 42(6):507-511. PubMed ID: 31045876
[TBL] [Abstract][Full Text] [Related]
5. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
Orom H; Homish DL; Homish GG; Underwood W
Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
[TBL] [Abstract][Full Text] [Related]
6. Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey.
Wei Y; Liu L; Li X; Song W; Zhong D; Cao X; Yuan D; Ming S; Zhang P; Wen Y;
J Cancer; 2019; 10(6):1496-1502. PubMed ID: 31031859
[No Abstract] [Full Text] [Related]
7. Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.
Schofield P; Gough K; Hyatt A; White A; Frydenberg M; Chambers S; Gordon LG; Gardiner R; Murphy DG; Cavedon L; Richards N; Murphy B; Quinn S; Juraskova I
Trials; 2021 Jan; 22(1):49. PubMed ID: 33430950
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol.
Xu J; Goodman M; Janisse J; Cher ML; Bock CH
BMJ Open; 2022 Feb; 12(2):e056675. PubMed ID: 35190441
[TBL] [Abstract][Full Text] [Related]
9. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
Hoffman RM; Lobo T; Van Den Eeden SK; Davis KM; Luta G; Leimpeter AD; Aaronson D; Penson DF; Taylor K
Med Decis Making; 2019 Nov; 39(8):962-974. PubMed ID: 31631745
[No Abstract] [Full Text] [Related]
10. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.
Ong WL; Evans SM; Evans M; Tacey M; Dodds L; Kearns P; Milne RL; Foroudi F; Millar J
Eur Urol Oncol; 2021 Apr; 4(2):319-322. PubMed ID: 31411964
[TBL] [Abstract][Full Text] [Related]
11. Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.
Xu J; Janisse J; Ruterbusch J; Ager J; Schwartz KL
J Racial Ethn Health Disparities; 2016 Mar; 3(1):35-45. PubMed ID: 26896103
[TBL] [Abstract][Full Text] [Related]
12. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
13. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
14. Active Surveillance-Is It Feasible for Intermediate-risk Localised Prostate Cancer?
Mukherjee S; Promponas I; Petrides N; Hossain D; Abbaraju J; Madaan S
Eur Urol Open Sci; 2021 Feb; 24():17-24. PubMed ID: 34337491
[TBL] [Abstract][Full Text] [Related]
15. Which Patients Report That Their Urologists Advised Them to Forgo Initial Treatment for Prostate Cancer?
Radhakrishnan A; Grande D; Mitra N; Pollack CE
Urology; 2018 May; 115():133-138. PubMed ID: 29477313
[TBL] [Abstract][Full Text] [Related]
16. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
17. Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
van Vugt HA; Roobol MJ; van der Poel HG; van Muilekom EH; Busstra M; Kil P; Oomens EH; Leliveld A; Bangma CH; Korfage I; Steyerberg EW
BJU Int; 2012 Jul; 110(2):180-7. PubMed ID: 22112199
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
Pollack CE; Bekelman JE; Epstein AJ; Liao K; Wong YN; Armstrong K
Med Care; 2011 Nov; 49(11):999-1006. PubMed ID: 22005606
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
Ma TM; Romero T; Nickols NG; Rettig MB; Garraway IP; Roach M; Michalski JM; Pisansky TM; Lee WR; Jones CU; Rosenthal SA; Wang C; Hartman H; Nguyen PL; Feng FY; Boutros PC; Saigal C; Chamie K; Jackson WC; Morgan TM; Mehra R; Salami SS; Vince R; Schaeffer EM; Mahal BA; Dess RT; Steinberg ML; Elashoff D; Sandler HM; Spratt DE; Kishan AU
JAMA Netw Open; 2021 Dec; 4(12):e2139769. PubMed ID: 34964855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
